- Exchange: NASDAQ CM
- Sector: Health Care
- Industry: Biotech & Pharma
- Sub-Industry: Specialty Pharma
Echo Therapeutics Inc+ Add to Watchlist
ECTE:US2.0399 USD 0.0301 1.45%
As of 17:20:00 ET on 01/26/2015.
Company Profile for Echo Therapeutics Inc (ECTE)
Echo Therapeutics Inc. is a specialty transdermal therapeutics and diagnostics company. The Company develops portfolio of topical formulations of established, FDA approved products using its proprietary Azone dermal penetration technology.
Echo Therapeutics Inc
Key Executives for Echo Therapeutics Inc (ECTE)
|Robert F Doman "Bob"Chairman||Scott W HollanderPresident/CEO|
|Alan W SchoenbartCFO/Secretary||Kenneth Gary "Ken"Senior VP:Rsch & Ops|
|Daniel Sunday "Dan"VP:Manufacturing & Global Supply Chain||Thomas Bishop "Tom"VP:Product Development|
|Christine H OlimpioDir:Investor Relations|